164 related articles for article (PubMed ID: 25613394)
1. Crucial role of the Rap G protein signal in Notch activation and leukemogenicity of T-cell acute lymphoblastic leukemia.
Doi K; Imai T; Kressler C; Yagita H; Agata Y; Vooijs M; Hamazaki Y; Inoue J; Minato N
Sci Rep; 2015 Jan; 5():7978. PubMed ID: 25613394
[TBL] [Abstract][Full Text] [Related]
2. Rap G protein signal in normal and disordered lymphohematopoiesis.
Minato N
Exp Cell Res; 2013 Sep; 319(15):2323-8. PubMed ID: 23603280
[TBL] [Abstract][Full Text] [Related]
3. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
[TBL] [Abstract][Full Text] [Related]
4. Essential role of Rap signal in pre-TCR-mediated beta-selection checkpoint in alphabeta T-cell development.
Kometani K; Moriyama M; Nakashima Y; Katayama Y; Wang SF; Yamasaki S; Saito T; Hattori M; Minato N
Blood; 2008 Dec; 112(12):4565-73. PubMed ID: 18802005
[TBL] [Abstract][Full Text] [Related]
5. Development of Notch-dependent T-cell leukemia by deregulated Rap1 signaling.
Wang SF; Aoki M; Nakashima Y; Shinozuka Y; Tanaka H; Taniwaki M; Hattori M; Minato N
Blood; 2008 Mar; 111(5):2878-86. PubMed ID: 18180377
[TBL] [Abstract][Full Text] [Related]
6. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
7. Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL.
Stein SJ; Mack EA; Rome KS; Pajcini KV; Ohtani T; Xu L; Li Y; Meijerink JP; Faryabi RB; Pear WS
PLoS One; 2016; 11(5):e0155408. PubMed ID: 27191957
[TBL] [Abstract][Full Text] [Related]
8. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
Rao SS; O'Neil J; Liberator CD; Hardwick JS; Dai X; Zhang T; Tyminski E; Yuan J; Kohl NE; Richon VM; Van der Ploeg LH; Carroll PM; Draetta GF; Look AT; Strack PR; Winter CG
Cancer Res; 2009 Apr; 69(7):3060-8. PubMed ID: 19318552
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
[TBL] [Abstract][Full Text] [Related]
11. Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma.
Zhang Z; Mitra RS; Henson BS; Datta NS; McCauley LK; Kumar P; Lee JS; Carey TE; D'Silva NJ
Am J Pathol; 2006 Feb; 168(2):585-96. PubMed ID: 16436672
[TBL] [Abstract][Full Text] [Related]
12. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.
Guo D; Ye J; Dai J; Li L; Chen F; Ma D; Ji C
Leuk Res; 2009 May; 33(5):678-85. PubMed ID: 19091404
[TBL] [Abstract][Full Text] [Related]
13. Divergent effects of supraphysiologic Notch signals on leukemia stem cells and hematopoietic stem cells.
Chiang MY; Shestova O; Xu L; Aster JC; Pear WS
Blood; 2013 Feb; 121(6):905-17. PubMed ID: 23115273
[TBL] [Abstract][Full Text] [Related]
14. Increased c-Myc activity and DNA damage in hematopoietic progenitors precede myeloproliferative disease in Spa-1-deficiency.
Tanaka H; Tamura A; Sekai M; Hamazaki Y; Minato N
Cancer Sci; 2011 Apr; 102(4):784-91. PubMed ID: 21205094
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Mechanisms of Drug Resistance in Leukemia.
Knoechel B; Aster JC
Cell Metab; 2015 Nov; 22(5):759-60. PubMed ID: 26536486
[TBL] [Abstract][Full Text] [Related]
16. Rap1 and SPA-1 in hematologic malignancy.
Kometani K; Ishida D; Hattori M; Minato N
Trends Mol Med; 2004 Aug; 10(8):401-8. PubMed ID: 15310461
[TBL] [Abstract][Full Text] [Related]
17. Antigen-driven T cell anergy and defective memory T cell response via deregulated Rap1 activation in SPA-1-deficient mice.
Ishida D; Yang H; Masuda K; Uesugi K; Kawamoto H; Hattori M; Minato N
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10919-24. PubMed ID: 12958214
[TBL] [Abstract][Full Text] [Related]
18. Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating its activity and subcellular localization.
Farina A; Hattori M; Qin J; Nakatani Y; Minato N; Ozato K
Mol Cell Biol; 2004 Oct; 24(20):9059-69. PubMed ID: 15456879
[TBL] [Abstract][Full Text] [Related]
19. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Rap-1 activation and early termination of immune synapse in CTLA-4-mediated negative signal.
Hara S; Nakaseko C; Yamasaki S; Hattori M; Bos JL; Saito Y; Minato N; Saito T
Hematology; 2009 Jun; 14(3):150-8. PubMed ID: 19490760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
